Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer

This prognostic study compares tissue-free circulating tumor DNA analysis to tissue-free assay with tumor-informed assay results for estimating recurrence in patients with triple negative breast cancer.

Corresponding Author: Nicholas C. Turner, MD, PhD, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, 237 Fulham Rd, London SW7 3RP, United Kingdom (nick.turner@icr.ac.uk).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.